Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
Wilhelm Kriz, … , Brigitte Kaissling, Michel Le Hir
Wilhelm Kriz, … , Brigitte Kaissling, Michel Le Hir
Published February 1, 2011
Citation Information: J Clin Invest. 2011;121(2):468-474. https://doi.org/10.1172/JCI44595.
View: Text | PDF
Personal perspective

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

  • Text
  • PDF
Abstract

Epithelial-mesenchymal transition (EMT) has become widely accepted as a mechanism by which injured renal tubular cells transform into mesenchymal cells that contribute to the development of fibrosis in chronic renal failure. However, an increasing number of studies raise doubts about the existence of this process in vivo. Herein, we review and summarize both sides of this debate, but it is our view that unequivocal evidence supporting EMT as an in vivo process in kidney fibrosis is lacking.

Authors

Wilhelm Kriz, Brigitte Kaissling, Michel Le Hir

×

Figure 4

Renal fibroblast.

Options: View larger image (or click on image) Download as PowerPoint
Renal fibroblast.
TEM of a fibroblast in the renal cortical interstitium...
TEM of a fibroblast in the renal cortical interstitium of a healthy rat. From the cell body, numerous processes emerge that make contacts with a capillary (C, arrows), a tubule (double arrow), and another fibroblast (arrowhead). Scale bar: 1 μm. Reproduced with permission from Histochemistry and Cell Biology (16).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts